Results 11 to 20 of about 179,384 (308)

Heart Failure With Preserved Ejection Fraction. [PDF]

New England Journal of Medicine, 2016
Heart failure (HF) is one of the largest drivers of morbidity and health care expenditure in the world and continues to increase in prevalence at an alarming rate.
Y. Reddy, B. Borlaug
semanticscholar   +17 more sources

Heart Failure with Preserved Ejection Fraction. [PDF]

Clinical Medicine, 2018
Heart failure with preserved ejection fraction (HFpEF) represents a heterogeneous collection of conditions that are unified by the presence of a left ventricular ejection fraction ≥50%, evidence of impaired diastolic function and elevated natriuretic ...
J. Gladden, Antoine H Chaanine, M. Redfield   +2 more
semanticscholar   +13 more sources

Spironolactone for heart failure with preserved ejection fraction. [PDF]

New England Journal of Medicine, 2014
BACKGROUND Mineralocorticoid-receptor antagonists improve the prognosis for patients with heart failure and a reduced left ventricular ejection fraction.
B. Pitt, M. Pfeffer, S. Assmann, R. Boineau, I. Anand, Brian Claggett, N. Clausell, Akshay S. Desai, R. Diaz, J. Fleg, I. Gordeev, B. Harty, J. Heitner, C. Kenwood, E. Lewis, E. O’Meara, J. Probstfield, T. Shaburishvili, Sanjiv J. Shah, S. Solomon, N. Sweitzer, Song Yang, S. Mckinlay   +22 more
semanticscholar   +5 more sources

Heart failure with preserved ejection fraction [PDF]

Pflügers Archiv - European Journal of Physiology, 2014
Heart failure (HF) is a clinical syndrome of diverse etiologies and can be associated with preserved, reduced, or mid-range ejection fraction (EF). In the community, heart failure with preserved ejection fraction (HFpEF) is emerging as the most common form of HF.
J. Gladden, W. Linke, M. Redfield
semanticscholar   +13 more sources

Heart failure with preserved ejection fraction. [PDF]

Global Cardiology Science and Practice, 2012
Heart failure with preserved ejection fraction (HFpEF) has recently emerged as a major cause of cardiovascular morbidity and mortality. Contrary to initial beliefs, HFpEF is now known to be as common as heart failure with reduced ejection fraction (HFrEF)
ElGuindy, A, Yacoub, MH
core   +6 more sources

Heart Failure With Preserved Ejection Fraction

Journal of Osteopathic Medicine, 2015
Abstract Heart failure with preserved ejection fraction (HFpEF) is a complex clinical condition. Initially called diastolic heart failure, it soon became clear that this condition is more than the opposite side of systolic heart failure. It is increasingly prevalent and lethal.
F. Rogers, Teja Gundala, Jahir E Ramos, Asif Serajian   +3 more
semanticscholar   +5 more sources

Heart failure with preserved ejection fraction. [PDF]

Circulation, 2011
It is now well established that among patients with the clinical syndrome of heart failure (HF), approximately half have preserved systolic function, known most commonly as heart failure with preserved ejection fraction (HFpEF). Although originally considered to be predominantly a syndrome that pathophysiologically involves abnormalities in diastolic ...
J. Udelson
semanticscholar   +5 more sources

Heart failure with preserved ejection fraction [PDF]

Journal of geriatric cardiology : JGC, 2013
Progressive aging of the population and prolongation of life expectancy have led to the rising prevalence of heart failure (HF). Despite the improvements in medical therapy, the mortality rate of this condition has remained unacceptably high, becoming ...
M. Rigolli, G. Whalley
semanticscholar   +6 more sources

Empagliflozin in Heart Failure with a Preserved Ejection Fraction.

New England Journal of Medicine, 2021
BACKGROUND Sodium-glucose cotransporter 2 inhibitors reduce the risk of hospitalization for heart failure in patients with heart failure and a reduced ejection fraction, but their effects in patients with heart failure and a preserved ejection fraction ...
S. Anker, J. Butler, G. Filippatos, J. Ferreira, E. Bocchi, M. Böhm, H. Brunner-la Rocca, D. Choi, V. Chopra, E. Chuquiure-Valenzuela, N. Giannetti, J. Gómez-Mesa, S. Janssens, J. Januzzi, J. González-Juanatey, B. Merkely, S. Nicholls, S. Perrone, I. Piña, P. Ponikowski, M. Senni, D. Sim, J. Špinar, I. Squire, S. Taddei, H. Tsutsui, S. Verma, D. Vinereanu, Jian Zhang, P. Carson, Carolyn S. P. Lam, N. Marx, C. Zeller, N. Sattar, W. Jamal, S. Schnaidt, J. Schnee, M. Brueckmann, S. Pocock, F. Zannad, M. Packer   +40 more
semanticscholar   +3 more sources

Semaglutide in Patients with Heart Failure with Preserved Ejection Fraction and Obesity.

New England Journal of Medicine, 2023
BACKGROUND Heart failure with preserved ejection fraction is increasing in prevalence and is associated with a high symptom burden and functional impairment, especially in persons with obesity.
M. Kosiborod, S. Z. Abildstrom, B. Borlaug, J. Butler, S. Rasmussen, M. Davies, G. Hovingh, D. Kitzman, M. Lindegaard, D. Møller, Sanjiv J. Shah, M. Treppendahl, S. Verma, W. Abhayaratna, F. Ahmed, V. Chopra, J. Ezekowitz, Michael Fu, Hiroshi Ito, M. Lelonek, V. Melenovský, B. Merkely, Julio Núñez, E. Perna, M. Schou, M. Senni, K. Sharma, P. van der Meer, Dirk von Lewinski, Dennis Wolf, M. Petrie   +30 more
semanticscholar   +3 more sources